{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T07:06:52Z","timestamp":1778569612297,"version":"3.51.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,4,28]],"date-time":"2017-04-28T00:00:00Z","timestamp":1493337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["81573730 and 81628017"],"award-info":[{"award-number":["81573730 and 81628017"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"crossref","award":["2016A020226047"],"award-info":[{"award-number":["2016A020226047"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s10067-017-3646-1","type":"journal-article","created":{"date-parts":[[2017,4,28]],"date-time":"2017-04-28T03:18:41Z","timestamp":1493349521000},"page":"19-27","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Taxol alleviates collagen-induced arthritis in mice by inhibiting the formation of microvessels"],"prefix":"10.1007","volume":"38","author":[{"given":"Juan","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhitao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shixian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junqing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianghui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoguang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,28]]},"reference":[{"key":"3646_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/BOR.0000000000000017","volume":"26","author":"MK Demoruelle","year":"2014","unstructured":"Demoruelle MK, Deane KD, Holers VM (2014) When and where does inflammation begin in rheumatoid arthritis? Curr Opin Rheumatol 26:64\u201371","journal-title":"Curr Opin Rheumatol"},{"key":"3646_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/rheumatology\/ket358","volume":"53","author":"P Geusens","year":"2013","unstructured":"Geusens P, van den Bergh J (2013) Bone erosions in rheumatoid arthritis. Rheumatology 53:4\u20135","journal-title":"Rheumatology"},{"key":"3646_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nrrheum.2012.23","volume":"8","author":"JS Smolen","year":"2012","unstructured":"Smolen JS, Aletaha D, Redlich K (2012) The pathogenesis of rheumatoid arthritis: new insights from old clinical data? Nat Rev Rheumatol 8:235\u2013243","journal-title":"Nat Rev Rheumatol"},{"key":"3646_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.smim.2011.01.014","volume":"23","author":"L Klareskog","year":"2011","unstructured":"Klareskog L, Malmstr\u00f6m V, Lundberg K, Padyukov L, Alfredsson L (2011) Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis. Semin Immunol 23:92\u201398","journal-title":"Semin Immunol"},{"key":"3646_CR5","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/ar2515","volume":"10","author":"Z Szekanecz","year":"2008","unstructured":"Szekanecz Z, Koch AE (2008) Vascular involvement in rheumatic diseases: \u2018vascular rheumatology\u2019. Arthritis Res Ther 10:224","journal-title":"Arthritis Res Ther"},{"key":"3646_CR6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10456-015-9477-2","volume":"18","author":"HA Elshabrawy","year":"2015","unstructured":"Elshabrawy HA, Chen Z, Volin MV, Ravella S, Virupannavar S, Shahrara S (2015) The pathogenic role of angiogenesis in rheumatoid arthritis. Angiogenesis 18:433\u2013448","journal-title":"Angiogenesis"},{"key":"3646_CR7","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/ncprheum0647","volume":"3","author":"Z Szekanecz","year":"2007","unstructured":"Szekanecz Z, Koch AE (2007) Mechanisms of disease: angiogenesis in inflammatory diseases. Nat Clin Pract Rheumatol 3:635\u2013643","journal-title":"Nat Clin Pract Rheumatol"},{"key":"3646_CR8","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.autrev.2011.04.020","volume":"10","author":"A Marrelli","year":"2011","unstructured":"Marrelli A, Cipriani P, Liakouli V, Carubbi F, Perricone C, Perricone R, Giacomelli R (2011) Angiogenesis in rheumatoid arthritis: a disease specific process or a common response to chronic inflammation? Autoimmun Rev 10:595\u2013598","journal-title":"Autoimmun Rev"},{"key":"3646_CR9","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.berh.2006.05.004","volume":"20","author":"DJ Veale","year":"2006","unstructured":"Veale DJ, Fearon U (2006) Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targeting. Best Pract Res Clin Rheumatol 20:941\u2013947","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"3646_CR10","first-page":"15","volume":"15","author":"EF Rosloniec","year":"2010","unstructured":"Rosloniec EF, Cremer M, Kang AH, Myers LK, Brand DD (2010) Collagen-induced arthritis. Curr Protoc Immunol 15:15","journal-title":"Curr Protoc Immunol"},{"key":"3646_CR11","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3109\/s10165-009-0210-0","volume":"19","author":"KS Park","year":"2009","unstructured":"Park KS, Park MJ, Cho ML, Kwok SK, Ju JH, Ko HJ, Park SH, Kim HY (2009) Type II collagen oral tolerance; mechanism and role in collagen-induced arthritis and rheumatoid arthritis. Mod Rheumatol 19:581\u2013589","journal-title":"Mod Rheumatol"},{"key":"3646_CR12","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2174\/1389557511313040004","volume":"13","author":"K Ledwitch","year":"2013","unstructured":"Ledwitch K, Ogburn R, Cox J, Graham R, Fritzsche A, Gosnell D, Manning T (2013) Taxol: efficacy against oral squamous cell carcinoma. Min Rev Med Chem 13:509\u2013521","journal-title":"Min Rev Med Chem"},{"key":"3646_CR13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2174\/1568009033481912","volume":"3","author":"A Gautam","year":"2003","unstructured":"Gautam A, Koshkina N (2003) Paclitaxel (taxol) and taxoid derivates for lung cancer treatment: potential for aerosol delivery. Curr Cancer Drug Targets 3:287\u2013296","journal-title":"Curr Cancer Drug Targets"},{"key":"3646_CR14","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1183\/09031936.00154206","volume":"30","author":"T Mirzapoiazova","year":"2007","unstructured":"Mirzapoiazova T, Kolosova IA, Moreno L, Sammani S, Garcia JGN, Verin AD (2007) Suppression of endotoxin-induced inflammation by taxol. Eur Respir J 30:429\u2013435","journal-title":"Eur Respir J"},{"key":"3646_CR15","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/path.2961","volume":"225","author":"L Sun","year":"2011","unstructured":"Sun L, Zhang D, Liu F, Xiang X, Ling G, Xiao L, Liu Y, Zhu X, Zhan M, Yang Y, Kondeti VK, Kanwar YS (2011) Low-dose paclitaxel ameliorates fibrosis in the remnant kidney model by down-regulating miR-192. J Pathol 225:364\u2013377","journal-title":"J Pathol"},{"key":"3646_CR16","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.3748\/wjg.v16.i26.3330","volume":"16","author":"J Zhou","year":"2010","unstructured":"Zhou J (2010) Paclitaxel ameliorates fibrosis in hepatic stellate cells via inhibition of TGF-\u03b2\/Smad activity. World J Gastroenterol 16:3330\u20133334","journal-title":"World J Gastroenterol"},{"key":"3646_CR17","doi-asserted-by":"publisher","first-page":"e354","DOI":"10.1371\/journal.pmed.0020354","volume":"2","author":"X Liu","year":"2005","unstructured":"Liu X, Zhu S, Wang T, Hummers L, Wigley FM, Goldschmidt-Clermont PJ, Dong C (2005) Paclitaxel modulates TGFbeta signaling in scleroderma skin grafts in immunodeficient mice. PLoS Med 2:e354","journal-title":"PLoS Med"},{"key":"3646_CR18","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1126\/science.1201148","volume":"331","author":"F Hellal","year":"2011","unstructured":"Hellal F, Hurtado A, Ruschel J, Flynn KC, Laskowski CJ, Umlauf M, Kapitein LC, Strikis D, Lemmon V, Bixby J, Hoogenraad CC, Bradke F (2011) Microtubule stabilization reduces scarring and causes axon regeneration after spinal cord injury. Science 331:928\u2013931","journal-title":"Science"},{"key":"3646_CR19","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.jvs.2008.04.039","volume":"47","author":"G Tepe","year":"2008","unstructured":"Tepe G, Zeller T, Albrecht T (2008) Local delivery of paclitaxel to inhibit re-stenosis during angioplasty of the leg. J Vasc Surg 47:1372","journal-title":"J Vasc Surg"},{"key":"3646_CR20","first-page":"2281","volume":"21","author":"IA Avramis","year":"2001","unstructured":"Avramis IA, Kwock R, Avramis VI (2001) Taxotere and vincristine inhibit the secretion of the angiogenesis inducing vascular endothelial growth factor (VEGF) by wild-type and drug-resistant human leukemia T-cell lines. Anticancer Res 21:2281\u20132286","journal-title":"Anticancer Res"},{"key":"3646_CR21","doi-asserted-by":"publisher","first-page":"9021","DOI":"10.1158\/0008-5472.CAN-04-4095","volume":"65","author":"D Escuin","year":"2005","unstructured":"Escuin D (2005) Both microtubule-stabilizing and microtubule-destabilizing drugs inhibit hypoxia-inducible factor-1 accumulation and activity by disrupting microtubule function. Cancer Res 65:9021\u20139028","journal-title":"Cancer Res"},{"key":"3646_CR22","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis. Lancet 388:2023\u20132038","journal-title":"Lancet"},{"key":"3646_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1476-9255-6-10","volume":"6","author":"B Liang","year":"2009","unstructured":"Liang B, Song Z, Wu B, Gardner D, Shealy D, Song XY, Wooley PH (2009) Evaluation of anti-IL-6 monoclonal antibody therapy using murine type II collagen-induced arthritis. J Inflamm (Lond) 6:10","journal-title":"J Inflamm (Lond)"},{"key":"3646_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s10456-015-9487-0","volume":"19","author":"L Semerano","year":"2016","unstructured":"Semerano L, Duvallet E, Belmellat N, Marival N, Schall N, Monteil M, Grouard-Vogel G, Bernier E, Lecouvey M, Hlawaty H, Muller S, Boissier MC, Assier E (2016) Targeting VEGF-A with a vaccine decreases inflammation and joint destruction in experimental arthritis. Angiogenesis 19:39\u201352","journal-title":"Angiogenesis"},{"key":"3646_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0163-7258(84)90025-1","volume":"25","author":"JJ Manfredi","year":"1984","unstructured":"Manfredi JJ, Horwitz SB (1984) Taxol: an antimitotic agent with a new mechanism of action. Pharmacol Ther 25:83\u2013125","journal-title":"Pharmacol Ther"},{"key":"3646_CR26","doi-asserted-by":"publisher","first-page":"R65","DOI":"10.1016\/S1074-5521(99)89002-4","volume":"6","author":"LA Amos","year":"1999","unstructured":"Amos LA, Lowe J (1999) How Taxol stabilises microtubule structure. Chem Biol 6:R65\u2013R69","journal-title":"Chem Biol"},{"key":"3646_CR27","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1038\/sj.onc.1207374","volume":"23","author":"R Bharadwaj","year":"2004","unstructured":"Bharadwaj R, Yu H (2004) The spindle checkpoint, aneuploidy, and cancer. Oncogene 23:2016\u20132027","journal-title":"Oncogene"},{"key":"3646_CR28","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1083\/jcb.200805072","volume":"182","author":"DA Brito","year":"2008","unstructured":"Brito DA, Yang Z, Rieder CL (2008) Microtubules do not promote mitotic slippage when the spindle assembly checkpoint cannot be satisfied. J Cell Biol 182:623\u2013629","journal-title":"J Cell Biol"},{"key":"3646_CR29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1479-5876-7-58","volume":"7","author":"R Kaneno","year":"2009","unstructured":"Kaneno R, Shurin GV, Tourkova IL, Shurin MR (2009) Chemomodulation of human dendritic cell function by antineoplastic agents in low noncytotoxic concentrations. J Transl Med 7:58","journal-title":"J Transl Med"},{"key":"3646_CR30","doi-asserted-by":"publisher","first-page":"137","DOI":"10.4049\/jimmunol.0900734","volume":"183","author":"GV Shurin","year":"2009","unstructured":"Shurin GV, Tourkova IL, Kaneno R, Shurin MR (2009) Chemotherapeutic agents in noncytotoxic concentrations increase antigen presentation by dendritic cells via an IL-12-dependent mechanism. J Immunol 183:137\u2013144","journal-title":"J Immunol"},{"key":"3646_CR31","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.4049\/jimmunol.1202781","volume":"190","author":"A Sevko","year":"2013","unstructured":"Sevko A, Michels T, Vrohlings M, Umansky L, Beckhove P, Kato M, Shurin GV, Shurin MR, Umansky V (2013) Antitumor effect of paclitaxel is mediated by inhibition of myeloid-derived suppressor cells and chronic inflammation in the spontaneous melanoma model. J Immunol 190:2464\u20132471","journal-title":"J Immunol"},{"key":"3646_CR32","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1165\/rcmb.2002-0075OC","volume":"28","author":"I Petrache","year":"2003","unstructured":"Petrache I, Birukova A, Ramirez SI, Garcia JGN, Verin AD (2003) The role of the microtubules in tumor necrosis factor-\u03b1\u2013induced endothelial cell permeability. Am J Resp Cell Mol 28:574\u2013581","journal-title":"Am J Resp Cell Mol"},{"key":"3646_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jcp.20055","volume":"201","author":"AA Birukova","year":"2004","unstructured":"Birukova AA, Smurova K, Birukov KG, Usatyuk P, Liu F, Kaibuchi K, Ricks-Cord A, Natarajan V, Alieva I, Garcia JG, Verin AD (2004) Microtubule disassembly induces cytoskeletal remodeling and lung vascular barrier dysfunction: role of Rho-dependent mechanisms. J Cell Physiol 201:55\u201370","journal-title":"J Cell Physiol"},{"key":"3646_CR34","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/art.1780370611","volume":"37","author":"E Brahn","year":"1994","unstructured":"Brahn E, Tang C, Banquerigo ML (1994) Regression of collagen-induced arthritis with taxol, a microtubule stabilizer. Arthritis Rheum 37:839\u2013845","journal-title":"Arthritis Rheum"},{"key":"3646_CR35","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1006\/clin.1997.4479","volume":"86","author":"AL Arsenault","year":"1998","unstructured":"Arsenault AL, Lhotak S, Hunter WL, Banquerigo ML, Brahn E (1998) Taxol involution of collagen-induced arthritis: ultrastructural correlation with the inhibition of synovitis and neovascularization. Clin Immunol Immunopathol 86:280\u2013289","journal-title":"Clin Immunol Immunopathol"},{"key":"3646_CR36","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/1097-0320(20010801)44:4<349::AID-CYTO1126>3.0.CO;2-O","volume":"44","author":"A Kurose","year":"2001","unstructured":"Kurose A, Yoshida W, Yoshida M, Sawai T (2001) Effects of paclitaxel on cultured synovial cells from patients with rheumatoid arthritis. Cytometry 44:349\u2013354","journal-title":"Cytometry"},{"key":"3646_CR37","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D","volume":"41","author":"AE Koch","year":"1998","unstructured":"Koch AE (1998) Review: angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum 41:951\u2013962","journal-title":"Arthritis Rheum"},{"key":"3646_CR38","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/ncprheum0559","volume":"3","author":"D Lainer-Carr","year":"2007","unstructured":"Lainer-Carr D, Brahn E (2007) Angiogenesis inhibition as a therapeutic approach for inflammatory synovitis. Nat Clin Pract Rheumatol 3:434\u2013442","journal-title":"Nat Clin Pract Rheumatol"},{"key":"3646_CR39","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/BOR.0b013e32805e87ae","volume":"19","author":"Z Szekanecz","year":"2007","unstructured":"Szekanecz Z, Koch AE (2007) Macrophages and their products in rheumatoid arthritis. Curr Opin Rheumatol 19:289\u2013295","journal-title":"Curr Opin Rheumatol"},{"key":"3646_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2008\/129873","volume":"2008","author":"S Yoo","year":"2008","unstructured":"Yoo S, Kwok S, Kim W (2008) Proinflammatory role of vascular endothelial growth factor in the pathogenesis of rheumatoid arthritis: prospects for therapeutic intervention. Mediat Inflamm 2008:1\u20136","journal-title":"Mediat Inflamm"},{"key":"3646_CR41","first-page":"321","volume":"19","author":"SS Lee","year":"2001","unstructured":"Lee SS, Joo YS, Kim WU, Min DJ, Min JK, Park SH, Cho CS, Kim HY (2001) Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol 19:321\u2013324","journal-title":"Clin Exp Rheumatol"},{"key":"3646_CR42","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.clim.2007.04.014","volume":"124","author":"G Clavel","year":"2007","unstructured":"Clavel G, Bessis N, Lemeiter D, Fardellone P, Mejjad O, M\u00e9nard JF, Pouplin S, Boumier P, Vittecoq O, Le Lo\u00ebt X, Boissier MC (2007) Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction. Clin Immunol 124:158\u2013164","journal-title":"Clin Immunol"},{"key":"3646_CR43","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s10067-008-1075-x","volume":"28","author":"ST Choi","year":"2009","unstructured":"Choi ST, Kim JH, Seok JY, Park YB, Lee SK (2009) Therapeutic effect of anti-vascular endothelial growth factor receptor I antibody in the established collagen-induced arthritis mouse model. Clin Rheumatol 28:333\u2013337","journal-title":"Clin Rheumatol"},{"key":"3646_CR44","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrrheum.2011.205","volume":"8","author":"S Konisti","year":"2012","unstructured":"Konisti S, Kiriakidis S, Paleolog EM (2012) Hypoxia\u2014a key regulator of angiogenesis and inflammation in rheumatoid arthritis. Nat Rev Rheumatol 8:153\u2013162","journal-title":"Nat Rev Rheumatol"},{"key":"3646_CR45","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1136\/annrheumdis-2012-202444","volume":"73","author":"F Hu","year":"2014","unstructured":"Hu F, Mu R, Zhu J, Shi L, Li Y, Liu X, Shao W, Li G, Li M, Su Y, Cohen PL, Qiu X, Li Z (2014) Hypoxia and hypoxia-inducible factor-1\u03b1 provoke toll-like receptor signalling-induced inflammation in rheumatoid arthritis. Ann Rheum Dis 73:928\u2013936","journal-title":"Ann Rheum Dis"},{"key":"3646_CR46","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.mam.2015.12.004","volume":"47-48","author":"EP Cummins","year":"2016","unstructured":"Cummins EP, Keogh CE, Crean D, Taylor CT (2016) The role of HIF in immunity and inflammation. Mol Asp Med 47-48:24\u201334","journal-title":"Mol Asp Med"},{"key":"3646_CR47","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S0092-8674(03)00154-5","volume":"112","author":"T Cramer","year":"2003","unstructured":"Cramer T, Yamanishi Y, Clausen BE, Forster I, Pawlinski R, Mackman N, Haase VH, Jaenisch R, Corr M, Nizet V, Firestein GS, Gerber HP, Ferrara N, Johnson RS (2003) HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112:645\u2013657","journal-title":"Cell"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-017-3646-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3646-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3646-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T08:55:57Z","timestamp":1567068957000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-017-3646-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,28]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["3646"],"URL":"https:\/\/doi.org\/10.1007\/s10067-017-3646-1","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,28]]},"assertion":[{"value":"1 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All procedures involving mice were approved by the Institutional Animal Ethics Committee of Nanfang Hospital (No. NFYY-2014-139).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval statement"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}